ABSTRACT -Soluble guanylyl cyclase (soluble GC) is an enzyme consisting of α and β subunits and catalyzes the conversion of GTP to cGMP. The formation of the heterodimer is essential for the activity of soluble GC. Each subunit of soluble GC has been shown to comprize three functionally different parts: a C-terminal catalytic domain, a central dimerization domain, and an N-terminal regulatory domain. The central dimerization domain of the β 1 subunit, which contains an N-terminal binding site (NBS) and a C-terminal binding site (CBS), has been postulated to be responsible for the formation of α / β heterodimer. In this study, we analyzed heterodimerization by the pull-down assay using the affinity between a histidine tag and Ni 2+ Sepharose after co-expression of various N-and C-terminally truncated FLAG-tagged mutants of the α 1 subunit and the histidine-tagged wild type of the β 1 subunit in the vaculovirus/Sf9 system, and demonstrated that the CBS-like sequence of the α 1 subunit is critical for the formation of the heterodimer with the β 1 subunit and the NBS-like sequence of the α 1 subunit is essential for the formation of the enzymatically active heterodimer, although this particular sequence was not involved in heterodimerization. The analysis of the secondary structure of the α 1 subunit predicted the existence of an amphipathic α -helix in residues 431-464. Experiments with site-directed α 1 subunit mutant proteins demonstrated that the amphipathicity of the α -helix is important for the formation of the heterodimer, and Leu 463 in the α -helix region plays a critical role in the formation of a properly arranged active center in the dimer.
INTRODUCTION
Both the soluble and membrane forms of guanylyl cyclases (GCs) catalyze the conversion of GTP to cGMP, which is a ubiquitous second messenger in intracellular signaling cascades and responsible for a wide variety of physiological responses (Drewett and Garbers, 1994; Garbers and Lowe, 1994; . Soluble GC is a heterodimer consisting of α and β subunits, and contains a prosthetic ferrous heme group to which nitric oxide (NO) binds with high affinity. The formation of an NO-heme complex and the subsequent conformational change in the heterodimer are responsible for the up to 200-fold increase in the catalytic rate of this enzyme (Gerzer et al ., 1981; Humbert et al ., 1990; Stone and Marletta, 1994) . In mammals, cDNAs for four soluble GC subunits ( α 1 , α 2 , β 1 , and β 2 ) have been isolated from various tissues (Koesling et al ., 1988; Koesling et al ., 1990; Yuen et al ., 1990; Harteneck et al ., 1991) . Both the α 1 / β 1 and α 2 / β 1 heterodimers have been shown to be enzymatically active when formed in an in vitro expression system (Russwurm et al ., 1991) . A single expression of either one of the subunits has been shown to yield an α 1 / α 1 -or a β 1 / β 1 -homodimer, although both homodimers were catalytically inactive (Zabel et al ., 1999) . In previous studies, we have isolated and characterized the cDNA and genomic DNA clones encoding the soluble GC subunits, OlGCS-α 1 and OlGCS-β 1 , both of which are aligned in tandem on the genome of the medaka fish Oryzias latipes (Mikami et al ., 1998 (Mikami et al ., , 1999 . We recently demonstrated that the medaka fish contains another type of a soluble GC subunit gene, OlGCS-α 2 , which is located on a different linkage group of OlGCS-α 1 and OlGCS-β 1 (Yao et al ., 2003) .
Each subunit of soluble GC can be divided functionally into three parts: a C-terminal catalytic domain, a central region commonly referred to as the dimerization domain, and an N-terminal regulatory domain participating in heme binding (Koesling, 1999) . The His 105 site in residue of the β 1 subunit has been identified as the proximal heme ligand site (Wedel et al ., 1994; Zhao et al ., 1998; Foerster et al ., 1996) .
The C-terminal catalytic domain is highly conserved among various soluble GC subunits and is thought to be responsible for catalysis, as based on its homology with a related domain of adenylyl cyclase (Koesling, 1999) . Dimerization has been attributed to the central region of the soluble GC subunits; this attribution is primarily based on studies of peptide receptor/membrane GCs (Wilson and Chinkers, 1996) . It was recently demonstrated that the dimerization domain of the β 1 subunit consists of 205 amino acid residues across the regulatory and central regions and contains discontinuous sequences consisting of 41 amino acid residues (N-terminal binding site: NBS) and 30 amino acid residues (C-terminal binding site: CBS), respectively, that facilitate the binding of the β 1 subunit to the α 1 subunit (Zhou et al ., 2004) . However, the function of the N-terminal portion of the α 1 subunit has remained unknown, although several studies have shown that the N-terminal portion of the α 1 subunit is critical for heme-binding (Wedel et al ., 1995) ; moreover, it was shown that deletion of the 259 N-terminal amino acids from the α 1 subunit exerted no effect whatsoever on the properties of the enzyme, and amino acids 259-364 of the α 1 subunit represent an important functional domain for the transduction of the NO-activation signal (Koglin and Behrends, 2003) . Although soluble GC has not yet been crystallized for X-ray diffraction analysis, it is predicted that its catalytic domain resembles that of the class III adenylyl cyclases (Tucker et al , 1998; Sunahara et al ., 1998) . Structural analysis of the catalytic core of the adenylyl cyclases has demonstrated an antiparallel orientation of the two catalytic domains (C 1 and C 2 ) with two pockets, the formation of each of which involves both of the catalytic domains (Zhang et al ., 1997; Tesmer et al ., 1997) .
To investigate the dimerization region of the α 1 subunit, we generated several recombinant soluble GC subunits in an expression system with Sf9 cells and performed a pulldown assay using the affinity between the histidine tag and Ni 2+ Sepharose. Here, we report that the NBS-like sequence of OlGCS-α 1 is not involved in the formation of the heterodimer with OlGCS-β 1 , but it does appear to play an important role in the formation of the enzymatically active heterodimer. We also report here that the CBS-like sequence of OlGCS-α 1 is involved in the formation of a heterodimer with OlGCS-β 1 and that the amphipathic α -helix of OlGCS-α 1 is critical for the formation of a heterodimer with OlGCS-β 1 .
MATERIALS AND METHODS
Construction of a plasmid for histidine-tagged OlGCS-β β β β 1 -full length protein (FL HT )
Total RNA was isolated from the adult brain of O. latipes by the acid/guanidinium/thiocyanate/phenol/chloroform extraction method (Chomczynski and Sacchi, 1987) . Total RNA (5 µ g) was used as the template to synthesize the first strand cDNA using an oligo(dT) primer, and the Super Script II preamplification system was used according to the manufacturer's protocol for first-strand cDNA synthesis (Gibco BRL, Tokyo, Japan). To obtain a C-terminal histidinetagged OlGCS-β 1 -full length protein (OlGCS-β 1 -FL HT ), we designed the following primers: 5'-GTG GAT CCA TGT ATG GTT TTG TGA AT-3' and 5'-CGC GTC GAC TTA GTG ATG GTG ATG GTG ATG TGC CTT GTC AGC GTC GCT GC-3'. PCR was performed using Ex Taq polymerase (TaKaRa, Otsu, Japan) according to manufacturer's protocol with the following PCR conditions: 30 cycles of 30 sec at 94 ° C, 30 sec at 50 ° C, 4 min at 72 ° C, and a final extension of 5 min at 72 ° C. The cDNA fragment amplified by the PCR was purified and subcloned into the plasmid vector pBluescript II KS(-) (Stratagene, La Jolla, CA, USA). A Bam HI/ Sal I insert from the OlGCS-β 1 clone in the pBluescript II KS(-) vector was ligated into the Bam HI/ SalI cut pFASTBAC1 vector (Invitrogen Japan K. K., Tokyo, Japan).
Construction of plasmids for FLAG-tagged OlGCS-α α α α 1 -full length protein (FL FLAG ) and its truncated mutant proteins
To obtain a C-terminal FLAG-tagged OlGCS-α 1 -full length protein (OlGCS-α 1 -FL FLAG ) and several N-terminal and C-terminal deletion mutant proteins of OlGCS-α 1 , we performed PCR using an OlGCS-α 1 clone in pBluescript II KS(-) as a template. PCR was performed with various primers using Pfu polymerase (TaKaRa) according to the manufacturer's protocol (Table 1 ). The following PCR parameters were used: 30 cycles of 30 sec at 94°C, 30 sec at each annealing temperature shown in Table 1 , and 2 min at 72°C, with a final extension of 5 min at 72°C. Each PCR product was purified and digested by SpeI and XhoI. The resulting SpeI/XhoI-cut PCR product was subcloned into the pFASTBAC1 vector.
Construction of plasmids for C-terminal FLAG-tagged sitedirected OlGCS-α α α α 1 mutant proteins Mutagenesis of OlGCS-α 1 was performed using the following primers: 5'-GCC CAG GAT GGC AAG AAG AAG CG-3' for L434K, 5'-GGC AGC CAA GGA AAA CGC TCA CC-3' for L445K, 5'-CGC TCA CCA AGC GAA GGA GGA GG-3' for L453K, and 5'-GAT CTT AAG TTT TCC ATT TTC CC-3' for L463K. As a template for the mutagenesis, we used the pFASTBAC1 vector containing the C-terminal FLAG-tagged intact OlGCS-α 1 -full length sequence. The mutagenesis was performed by the site-directed and semi-random mutagenesis procedure (Sawano and Miyawaki, 2000) .
Generation of recombinant baculovirus
The accuracy of the sequences of all clones was confirmed by DNA sequencing. Each sequence was confirmed by the dideoxy chain termination procedure (Sanger et al., 1992) with an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Osaka, Japan) and analyzed with GENETYX-MAC/version 7.2.0 software (Software Development, Tokyo, Japan). Recombinant baculovirus of each respective clone was generated according to a BAC-TO-BAC Baculovirus Expression System (Invitrogen Japan K. K.).
Sf9 cell culture, expression of recombinant soluble GC subunit constructs and mutants, and cytosol preparation
Sf9 cells were cultured in SF-900 II serum-free medium supplemented with 50 µg/ml streptomycin, 50 U/ml penicillin, and 20% fetal bovine serum (FBS). Spinner cultures were grown to a cell density of 3.0×10 6 cells/ml and then the cultures were diluted to 2.0×10 6 cells/ml in a tissue culture flask. Ten ml of the culture medium containing Sf9 cells (2.0×10 6 cells/ml) were infected with each virus stock of OlGCS-α 1 or were co-infected with OlGCS-β 1 -FL HT -containing virus (ratio 1:1), and then the samples were cultured for an additional 4 days at 37°C. All subsequent experiments were carried out at 4°C. The cells were harvested by centrifugation at 1,000 g for 5 min. The resulting pellet was washed in 1 ml of icecold phosphate-buffered saline (PBS), pH 6.2, and then was resuspended in 500 µl of an ice-cold lysis buffer for the pull-down assay (50 mM phosphate buffer, pH 7.2, containing 100 mM NaCl, 10% glycerol, and 0.1% protease inhibitor mixture in DMSO solution) (Wako, Osaka, Japan) or the pellet was resuspended in lysis buffer to detect GC activity (20 mM Tris-HCl, pH 6.8, 90 mM NaCl, 10% glycerol, and 0.1% protease inhibitor mixture-dimethylsulfoxide (DMSO) solution). The suspension was sonicated and then centrifuged at 15,000 g for 20 min, and the resulting supernatant fraction was collected and used for subsequent experiments.
Determination of protein concentration, Western blot analysis, and pull-down assay
The protein concentration was determined by the BCA method using BCA protein assay reagent (PIERCE, Rockford, IL, USA). Before each pull-down assay, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting were used to confirm that similar levels of protein were expressed in each lysate. The cell lysates were subjected to SDS-PAGE on a 10% polyacrylamide gel and transferred to PVDF membranes, which were blocked with 2% dry milk in TPBS (PBS, pH 7.4, containing 0.1% Tween 20) for 15 min at room temperature, rinsed, and incubated overnight at 4°C with anti-His-Tag antibody (MBL, Nagoya, Japan) or ANTI-FLAG M2 monoclonal antibody-alkaline phosphatase conjugate (SIGMA, Saint Louis, MO, USA) in TPBS containing 0.2% dry milk. Subsequently, the anti-His-Tag antibodytreated membrane was incubated with secondary antibody for 1 h at room temperature. Immunoreacted proteins were detected using ready-to use CDP-Star (Roche, Tokyo, Japan) or Western blot detection reagents (Amersham). The density of each band was determined by scanning the images using Scion Image Beta 4.0.2 (Scion corporation, Frederick, MD, USA). The lysis buffer for the pull-down assay containing 500 µg protein was incubated overnight at 4°C with 150 µl of chelating Sepharose (Amersham Pharmacia Biotech, Tokyo, Japan), which was preincubated in a total volume of 600 µl containing 75 µl of 0.2 M NiCl 2 for 5 min according to the manufacturer's protocol. Each sample was washed 3 times with 750 µl of the ice-cold lysis buffer used for the pull-down assay, and then the samples were washed 3 times with 300 µl of the ice-cold lysis buffer used for the pull-down assay, to which 15 mM imidazole had been added. The proteins were then eluted with the ice-cold lysis buffer used for the pull-down assay, which also contained 150 mM imidazole. The eluted proteins were subjected to SDS-PAGE and Western blot analysis, as described above.
Assay of GC activity
Before the assay of GC activity was performed, SDS-PAGE and Western blot analysis were carried out in order to confirm that similar levels of protein were expressed in each cytosolic fraction. The GC activity of the cytosolic fraction (50 µg protein/assay tube) was determined in a total volume of 250 µl by incubation for 15 min at 37°C in an assay solution (50 mM Tris-HCl, pH 7.5, 4 mM MgCl 2 , 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 7.5 mM creatine phosphate, 25 U/ml creatine phosphokinase, and 1 mM GTP) with or without 1 mM sodium nitroprusside dihydrate (SNP). The reaction was stopped by boiling the sample for 3 min, and then each assay tube was centrifuged at 15,000 g for 10 min. The amount of cGMP in the supernatant was determined by use of a cGMP enzyme immunoassay system (Amersham Biosciences, Tokyo, Japan).
RESULTS AND DISCUSSION
Identification of N-terminal binding site (NBS) and C-terminal binding site (CBS) of OlGCS-α α α α 1 To assign the putative NBS-and CBS-like sequences of OlGCS-α 1 , the amino acid sequence of OlGCS-α 1 was aligned with that of rat soluble GC-α 1 . The sequence identities of the NBS-like sequence of OlGCS-α 1 at positions 280-321 and the CBS-like sequence of OlGCS-α 1 at positions 448-477 to those of the corresponding rat soluble GC-α 1 were 45.2 and 90%, respectively. To define the binding ability of the NBS-like sequence of OlGCS-α 1 and the CBSlike sequence of OlGCS-α 1 to OlGCS-β 1 , we generated FLAG-tagged N-terminal deletion mutants and C-terminal deletion mutants of OlGCS-α 1 (Fig. 1) , and both types of mutant were separately expressed or co-expressed with the OlGCS-β 1 -FL HT in Sf9 cells.
To examine the binding ability of the NBS-like sequence to OlGCS-β 1 -FL HT , we performed a pull-down assay ( Fig. 2A) . OlGCS-α 1 -FL FLAG , OlGCS-α 1 [280-678] FLAG , and OlGCS- We then examined the binding ability of the C-terminal deletion mutant proteins of OlGCS-α 1 to OlGCS-β 1 . Coexpression of OlGCS-α 1 FLAG or OlGCS-α 1 FLAG with OlGCS-β 1 -FL HT was followed by pull-down assay and Western blot analysis. As shown in Fig. 2B FLAG was co-expressed with OlGCS-β 1 -FL HT in Sf9 cells, and the GC activity of the cytosolic fraction of each sample was measured. As shown in Fig. 3 , α 1 [280-678] FLAG /β 1 -FL HT showed basal and SNP-stimulated GC activity to almost the same extent as that of the control soluble GC (α 1 -FL FLAG /β 1 -FL HT ), although α 1 -[322-678] FLAG /β 1 -FL HT did not exhibit any GC activity with or without SNP. Therefore, we predicted that the NBSlike sequence of OlGCS-α 1 (amino acids 280-321) plays an important role in the correct formation of the active center with respect to the counterpart. This interpretation of the findings would be in good agreement with the results demonstrating that the β 1 subunit lacking amino acids at position 204-303 (containing the NBS: amino acids positions 204-244) failed to show GC activity when co-expressed with the α 1 subunit, although this β 1 subunit exhibited the ability to bind to the α 1 subunit at reduced levels (Zhou et al., 2004) . In a recent study, it was reported that the N-terminal binding site of the bovine a 1 subunit (amino acid positions 61-128) plays a major role in heterodimerization (Wagner et al., 2005) . However, in this study, we did not observe such ability in the amino acids at positions 61-128. Here, we per- formed both a pull-down assay and an assay to determine GC activity, and we demonstrated that OlGCS-α 1 FLAG was able to form a heterodimer with OlGCS-β 1 -FL HT .
Identification of amphipathic α α α α-helix mediating heterodimerization between OlGCS-α α α α 1 and OlGCS-β β β β 1 To gain a better understanding of the nature of the CBS-like sequence of OlGCS-α 1 necessary for heterodimerization and GC activity, we predicted the secondary structure of OlGCS-α 1 using the PredictProtein server (http:// www.embl-heidelberg.de/predictprotein/) and found that OlGCS-α 1 is able to form an amphipathic α-helix structure (Fig. 4) . It has been reported that amphipathic α-helices often mediate protein-protein interactions (Carr et al., 1991) . Therefore, we investigated whether or not the amphipathic α-helix in the α 1 subunit was able to mediate the heterodimerization of both subunits of soluble GC after the introduction of a site-directed mutation to the α 1 subunit. To disturb the amphipathicity of the α-helix, we focused on the four Leu residues (Leu ) as shown in the shaded boxes in Fig. 4B ; all of these Leu residues were predicted to be located exclusively on one side of the α-helix. Various site-directed mutant proteins were generated as described in Materials and Methods. According to the prediction of the secondary structure of the α 1 subunit that was carried out using the PredictProtein server, the α-helix structure was expected to be maintained, even after these four Leu residues were converted to Lys residues, thus leading to the loss of amphipathicity. OlGCS-α 1 -L434K FLAG , L445K FLAG , L463K FLAG , L434, 445, 463K FLAG , or L434, 445, 452, 463K FLAG was co-expressed with OlGCS-β 1 -FL HT in Sf9 cells, and the GC activity of each of the resulting cytosolic fractions was measured with or without SNP. As shown in Fig. 5 , α 1 -L434K FLAG /β 1 -FL HT and α 1 -L445K FLAG /β 1 -FL HT showed almost the same basal and SNP-stimulated GC activities as those of α 1 -FL FLAG /β 1 -FL HT , but α 1 -L463K FLAG /β 1 -FL HT , L434, 445, 463K FLAG /β 1 -FL HT , and L434, 445, 452, 463K FLAG /β 1 -FL HT exhibited neither basal GC activity nor SNP-induced GC activity. To investigate the binding ability of each site-directed mutant protein to OlGCS-β 1 -FL HT , we performed a pull-down assay. As shown in Fig. 6 , the binding ability of OlGCS-α 1 -L434, 445, 463K FLAG and OlGCS-α 1 -L434, 445, 452, 463K FLAG to OlGCS-β 1 -FL HT was remarkably reduced, although α 1 -L434K FLAG and α 1 -L445K FLAG both maintained their ability to bind to OlGCS-β 1 -FL HT . These results suggest that the amphipathicity in the putative α-helix region of OlGCS-α 1 is important for the formation of a heterodimer with OlGCS-β 1 .
The amphipathicity of the α-helix in OlGCS-α 1 [1-448] FLAG would be expected to be incomplete due to the lack of the C-terminal half of the putative amphipathic α-helix (see Fig. 1 ), which is likely to be a major reason for the inability of OlGCS-α 1 FLAG to bind to OlGCS-β 1 . Surprisingly, OlGCS-α 1 -L463K FLAG also maintained its binding ability to OlGCS-β 1 -FL HT , although the α 1 -L463K FLAG /β 1 -FL HT did not exhibit any GC activity, suggesting that the formation of a heterodimer of OlGCS-α 1 with OlGCS-β 1 is not sufficient for the enzyme GC activity, probably due to inadequate heterodimerization, which in turn would lead to the formation of an inadequate active center. As shown in Fig.  4A , Leu 463 is conserved among the soluble GC-α 1 subunits of various species and is located in the C-terminal end of the amphipathic α-helix. In order to form an enzymatically active heterodimer, it appears to be essential that the active center is correctly formed between the catalytic domains of the α and β subunits. The conversion of Leu 463 to Lys in OlGCS-α 1 might have led to the detachment of the hydrophobic bond at the C-terminal end of the amphipathic α-helix, although the remainder of the amphipathic α-helix maintained its hydrophobic bonds. The detachment of this region appears to lead to the formation of an incorrect active center between both domains of the catalytic subunits. This interpretation of the findings might account for why L463K FLAG / β 1 -FL HT did not show any GC activity. As shown in Fig. 4A , the amino acid sequence in this region varies among the soluble GC-α 1 subunits of various species; changes in this amino acid sequence were not found to affect the formation of the putative amphipathic α-helix, suggesting that the amphipathic α-helix plays a critical role in the heterodimerization of the soluble GC α 1 -subunit with the soluble GC-β 1 subunit. In addition, the analysis of the secondary structure of OlGCS-β 1 carried out with the PredictProtein server predicted that OlGCS-β 1 forms an amphipathic α-helix, and a similar analysis of OlGCS-α 2 also resulted in the prediction that OlGCS-α 2 forms an amphipathic α-helix. These results strongly suggest that the amphipathic α-helix mediates the heterodimerization of the soluble GC-α 1 subunit with soluble GC-β 1 subunits. 
